Wallace DJ, Ginzler EM, Merrill JT, et al. Sustained safety and efficacy over 10 years with belimumab (BEL) plus standard systemic lupus erythematosus (SLE) therapy (SOC) in patients with SLE. EULAR 2017, #OP0232.
Brepocitinib verbetert gewrichts- en huidverschijnselen van PsA
nov 2021 | Arthritis psoriatica